Dokument je izvleček s spletišča EUR-Lex.
Dokument 62024TB0666
Case T-666/24 R: Order of the President of the General Court of 27 March 2025 – Teva Pharma v EMA (Interim relief – Access to documents – Regulation (EC) No 1049/2001 – Documents relating to the EMA’s scientific advice given pursuant to Article 57(1)(n) of Regulation (EC) No 726/2004 – Decision to grant a third party access to the documents – Application for suspension of operation of a measure – No urgency)
Case T-666/24 R: Order of the President of the General Court of 27 March 2025 – Teva Pharma v EMA (Interim relief – Access to documents – Regulation (EC) No 1049/2001 – Documents relating to the EMA’s scientific advice given pursuant to Article 57(1)(n) of Regulation (EC) No 726/2004 – Decision to grant a third party access to the documents – Application for suspension of operation of a measure – No urgency)
Case T-666/24 R: Order of the President of the General Court of 27 March 2025 – Teva Pharma v EMA (Interim relief – Access to documents – Regulation (EC) No 1049/2001 – Documents relating to the EMA’s scientific advice given pursuant to Article 57(1)(n) of Regulation (EC) No 726/2004 – Decision to grant a third party access to the documents – Application for suspension of operation of a measure – No urgency)
OJ C, C/2025/2557, 12.5.2025, ELI: http://data.europa.eu/eli/C/2025/2557/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
Official Journal |
EN C series |
|
C/2025/2557 |
12.5.2025 |
Order of the President of the General Court of 27 March 2025 – Teva Pharma v EMA
(Case T-666/24 R)
(Interim relief - Access to documents - Regulation (EC) No 1049/2001 - Documents relating to the EMA’s scientific advice given pursuant to Article 57(1)(n) of Regulation (EC) No 726/2004 - Decision to grant a third party access to the documents - Application for suspension of operation of a measure - No urgency)
(C/2025/2557)
Language of the case: English
Parties
Applicant: Teva Pharma BV (Haarlem, Netherlands) (represented by: C. Lindenthal and A. Säurig, lawyers)
Defendant: European Medicines Agency (represented by: G. Gavriilidou, S. Drosos and G. Ramo, acting as Agents)
Re:
By its application based on Articles 278 and 279 TFEU, the applicant seeks suspension of the operation of Decision EMA/391476/2024 Rev.1 of the European Medicines Agency (EMA) of 28 October 2024 granting a third party, under Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to a document relating to scientific advice concerning the medicinal product ferric carboxymaltose, subject to certain redactions.
Operative part of the order
|
1. |
The application for interim measures is dismissed. |
|
2. |
The order of 30 December 2024, Teva Pharma v EMA (T-666/24 R), is cancelled. |
|
3. |
The costs are reserved. |
ELI: http://data.europa.eu/eli/C/2025/2557/oj
ISSN 1977-091X (electronic edition)